Kamada’s IgG treatment aids patient recovery in Covid-19 trial,

Kamada has reported top-line results from its Phase I/II clinical trial of anti-SARS-CoV-2 plasma-derived hyperimmune globulin (IgG) treating …, Kamada has reported top-line results from its Phase I/II clinical trial of anti-SARS-CoV-2 plasma-derived hyperimmune globulin (IgG) treating …, Read More

Scroll to Top